The present results demonstrated that Lsm1 suppressed prostate cancer metastasis through down-regulation, similar to the cases with the known metastasis suppressors, KAI1 or CD44, and we can speculate that the mechanism of decreased expression of this gene is reduction of gene dosage by allelic loss. This evidence concerns the gene CD82 and prostate carcinoma.